{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:58:10Z","timestamp":1790128690867,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100031645","name":"Novartis Italia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100031645","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-025-13122-9","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T23:27:23Z","timestamp":1753226843000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Burden of chronic spontaneous urticaria in Italy through healthcare resource utilization and direct costs: a retrospective analysis of real-world using administrative healthcare data"],"prefix":"10.1186","volume":"25","author":[{"given":"Giulia","family":"Ronconi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Dondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Calabria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Dondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Dell\u2019Anno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Casoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diletta","family":"Valsecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Bonavita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eustachio","family":"Nettis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nello","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8648-8961","authenticated-orcid":false,"given":"Carlo","family":"Piccinni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"issue":"6","key":"13122_CR1","doi-asserted-by":"publisher","first-page":"100533","DOI":"10.1016\/j.waojou.2021.100533","volume":"14","author":"M S\u00e1nchez-Borges","year":"2021","unstructured":"S\u00e1nchez-Borges M, Ansotegui IJ, Baiardini I, Bernstein J, Canonica GW, Ebisawa M, et al. The challenges of chronic urticaria part 1: epidemiology, immunopathogenesis, comorbidities, quality of life, and management. World Allergy Organ J. 2021;14(6):100533.","journal-title":"World Allergy Organ J"},{"issue":"4","key":"13122_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40266-015-0249-x","volume":"32","author":"MT Ventura","year":"2015","unstructured":"Ventura MT, Cassano N, Romita P, Vestita M, Foti C, Vena GA. Management of chronic spontaneous urticaria in the elderly. Drugs Aging. 2015;32(4):271\u201382.","journal-title":"Drugs Aging"},{"key":"13122_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12948-020-00123-8","volume":"18","author":"E Nettis","year":"2020","unstructured":"Nettis E, Foti C, Ambrifi M, Baiardini I, Bianchi L, Borghi A, et al. Urticaria: recommendations from the Italian society of allergology, asthma and clinical immunology and the Italian society of allergological, occupational and environmental dermatology. Clin Mol Allergy. 2020;18:8.","journal-title":"Clin Mol Allergy"},{"issue":"12","key":"13122_CR4","doi-asserted-by":"publisher","first-page":"100470","DOI":"10.1016\/j.waojou.2020.100470","volume":"13","author":"O Rossi","year":"2020","unstructured":"Rossi O, Piccirillo A, Iemoli E, Patrizi A, Stingeni L, Calvieri S, et al. Socio-economic burden and resource utilisation in Italian patients with chronic urticaria: 2-year data from the AWARE study. World Allergy Organ J. 2020;13(12):100470.","journal-title":"World Allergy Organ J"},{"issue":"3","key":"13122_CR5","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/all.15090","volume":"77","author":"T Zuberbier","year":"2022","unstructured":"Zuberbier T, Abdul Latiff AH, Abuzakouk M, Aquilina S, Asero R, Baker D, et al. The international eaaci\/ga\u00b2len\/euroguiderm\/apaaaci guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022;77(3):734\u201366.","journal-title":"Allergy"},{"issue":"12","key":"13122_CR6","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1111\/all.13209","volume":"72","author":"M Maurer","year":"2017","unstructured":"Maurer M, Abuzakouk M, B\u00e9rard F, Canonica W, Oude Elberink H, Gim\u00e9nez-Arnau A, et al. The burden of chronic spontaneous urticaria is substantial: Real-world evidence from ASSURE-CSU. Allergy. 2017;72(12):2005\u201316.","journal-title":"Allergy"},{"issue":"3","key":"13122_CR7","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s13555-021-00537-5","volume":"11","author":"N Wagner","year":"2021","unstructured":"Wagner N, Zink A, Hell K, Reinhardt M, Romer K, Hillmann E, et al. Patients with chronic urticaria remain largely undertreated: results from the DERMLINE online survey. Dermatology Therapy. 2021;11(3):1027\u201339.","journal-title":"Dermatology Therapy"},{"issue":"8","key":"13122_CR8","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1080\/03007995.2019.1586222","volume":"35","author":"B Hoskin","year":"2019","unstructured":"Hoskin B, Ortiz B, Paknis B, Kavati A. Exploring the real-world profile of refractory and non-refractory chronic idiopathic urticaria in the USA: clinical burden and healthcare resource use. Curr Med Res Opin. 2019;35(8):1387\u201395.","journal-title":"Curr Med Res Opin"},{"key":"13122_CR9","doi-asserted-by":"publisher","unstructured":"Pereira A, Xar\u00e1 J, Flor D, Gon\u00e7alo M. Omalizumab and new therapeutic targets in chronic spontaneous urticaria. Portuguese J Dermatology Venereol. 2024;82. https:\/\/doi.org\/10.24875\/PJDV.24000013.","DOI":"10.24875\/PJDV.24000013"},{"issue":"10","key":"13122_CR10","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1111\/cea.13716","volume":"50","author":"M Maurer","year":"2020","unstructured":"Maurer M, Costa C, Gimenez Arnau A, Guillet G, Labrador-Horrillo M, Lapeere H, et al. Antihistamine-resistant chronic spontaneous urticaria remains undertreated: 2-year data from the AWARE study. Clin Exp Allergy. 2020;50(10):1166\u201375.","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"13122_CR11","doi-asserted-by":"publisher","first-page":"100546","DOI":"10.1016\/j.waojou.2021.100546","volume":"14","author":"M S\u00e1nchez-Borges","year":"2021","unstructured":"S\u00e1nchez-Borges M, Ansotegui IJ, Baiardini I, Bernstein J, Canonica GW, Ebisawa M, et al. The challenges of chronic urticaria part 2: Pharmacological treatment, chronic inducible urticaria, urticaria in special situations. World Allergy Organ J. 2021;14(6):100546.","journal-title":"World Allergy Organ J"},{"key":"13122_CR12","doi-asserted-by":"publisher","unstructured":"Fidelia Cascini. Secondary use of electronic health data. Public health perspectives, use cases and challenges. Springer nature link. Springer Nature; 2025. https:\/\/link.springer.com\/book\/. https:\/\/doi.org\/10.1007\/978-3-031-88497-9.","DOI":"10.1007\/978-3-031-88497-9"},{"key":"13122_CR13","unstructured":"ISTAT. Demo Istat. Bilancio demografico e popolazione residente [Demographics and resident population]. Available from: https:\/\/demo.istat.it\/."},{"key":"13122_CR14","unstructured":"European Parliament and Council of the European Union. Regulation (EU) 536\/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing directive 2001\/20\/EC. 2014. Available from\u00a0https:\/\/eur-lex.europa.eu\/eli\/reg\/2014\/536\/oj\/eng."},{"key":"13122_CR15","unstructured":"Regulation (EU). 2016\/679 of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95\/46\/EC (General Data Protection Regulation). 2016. Available from\u00a0https:\/\/eur-lex.europa.eu\/eli\/reg\/2016\/679\/oj\/eng."},{"key":"13122_CR16","unstructured":"Garante per la protezione dei dati personali [Authority for the protection of personal data]. Provvedimento recante Le prescrizioni relative al Trattamento Di categorie particolari Di dati, Ai sensi Dell\u2019art. 21, Comma 1 Del d.lgs. 10 agosto 2018, n. 101 [Provision for the processing of particular categories of data]. Gazzetta Ufficiale [Official Gazette] Serie Generale n.176 del 29 luglio 2019."},{"key":"13122_CR17","unstructured":"Italian Ministry of Health. Decreto 30 novembre 2021. Misure volte a facilitare e sostenere la realizzazione degli studi clinici di medicinali senza scopo di lucro e degli studi osservazionali e a disciplinare la cessione di dati e risultati di sperimentazioni senza scopo di lucro a fini registrativi, ai sensi dell\u2019art. 1, comma 1, lettera c), del decreto legislativo 14 maggio 2019, n. 52. (22A01189). Gazzetta Ufficiale [Official Gazette] Serie Generale n. 42 del 19 febbraio 2022."},{"issue":"5","key":"13122_CR18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.anai.2015.02.003","volume":"114","author":"D Cherepanov","year":"2015","unstructured":"Cherepanov D, Raimundo K, Chang E, Eagan M, Zazzali JL, Solari PG, et al. Validation of an ICD-9\u2013based claims algorithm for identifying patients with chronic idiopathic\/spontaneous urticaria. Ann Allergy Asthma Immunol. 2015;114(5):393\u20138.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"13122_CR19","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1111\/bjd.14470","volume":"174","author":"F Lapi","year":"2016","unstructured":"Lapi F, Cassano N, Pegoraro V, Cataldo N, Heiman F, Cricelli I, et al. Epidemiology of chronic spontaneous urticaria: results from a nationwide, population-based study in Italy. Br J Dermatol. 2016;174(5):996\u20131004.","journal-title":"Br J Dermatol"},{"issue":"2","key":"13122_CR20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.anai.2011.10.018","volume":"108","author":"JL Zazzali","year":"2012","unstructured":"Zazzali JL, Broder MS, Chang E, Chiu MW, Hogan DJ. Cost, utilization, and patterns of medication use associated with chronic idiopathic urticaria. Ann Allergy Asthma Immunol. 2012;108(2):98\u2013102.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"13122_CR21","unstructured":"WHO, ATC\/DDD Index. 2022 2022. Available from: https:\/\/www.whocc.no\/atc_ddd_index\/."},{"issue":"4","key":"13122_CR22","doi-asserted-by":"publisher","first-page":"e13458","DOI":"10.1111\/dth.13458","volume":"33","author":"S Corrao","year":"2020","unstructured":"Corrao S, Prestigiacomo MA, Angileri RG, Natoli G, Argano C. Real world evidence on treatment of chronic spontaneous urticaria with omalizumab: preliminary data. Dermatol Ther. 2020;33(4):e13458.","journal-title":"Dermatol Ther"},{"issue":"3","key":"13122_CR23","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/bjd.20415","volume":"185","author":"F Hacard","year":"2021","unstructured":"Hacard F, Giraudeau B, d\u2019Acremont G, Jegou MH, Jonville-Bera AP, Munck S, et al. Guidelines for the management of chronic spontaneous urticaria: recommendations supported by the centre of evidence of the French society of dermatology. Br J Dermatol. 2021;185(3):658\u201360.","journal-title":"Br J Dermatol"},{"issue":"1","key":"13122_CR24","first-page":"39","volume":"153","author":"GA Vena","year":"2018","unstructured":"Vena GA, Cassano N, Pegoraro V, Cataldo N, Heiman F, Cricelli I, et al. Medication patterns in chronic spontaneous urticaria: results from a nationwide investigation in the primary care setting in Italy. G Ital Dermatol Venereol. 2018;153(1):39\u201342.","journal-title":"G Ital Dermatol Venereol"},{"key":"13122_CR25","unstructured":"Agenzia Italiana del Farmaco. Regime di rimborsabilit\u00e0 e prezzo a seguito di nuove indicazioni terapeutiche del medicinale per uso umano \u00abXolair\u00bb. (Determina n. 1060\/2015). G.U. del 21.08.2015 Serie Generale n.193. 2015."},{"key":"13122_CR26","unstructured":"Agenzia Italiana del Farmaco. Aggiornamento PT XOLAIR (CSU)\u2013 pazienti con data di valutazione antecedente al 17\/01\/2023 [Updated Therapeutic plan Xolair (CSU) - patients assessed before 17\/01\/2023] 2023. Available from: https:\/\/www.aifa.gov.it\/-\/aggiornamento-pt-xolair."},{"issue":"8","key":"13122_CR27","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1016\/j.jaip.2023.04.050","volume":"11","author":"JH Lee","year":"2023","unstructured":"Lee JH, Shin E, Kim HK, Song WJ, Kwon HS, Kim TB, et al. Exacerbation of chronic spontaneous urticaria following coronavirus disease 2019 (COVID-19) vaccination in Omalizumab-Treated patients. J Allergy Clin Immunol Pract. 2023;11(8):2403\u201310.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"13122_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40272-019-00365-3","volume":"22","author":"PV Williams","year":"2020","unstructured":"Williams PV. Pharmacologic management of chronic urticaria in pediatric patients: the gap between guidelines and practice. Paediatr Drugs. 2020;22(1):21\u20138.","journal-title":"Paediatr Drugs"},{"issue":"3","key":"13122_CR29","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/cea.12494","volume":"45","author":"RJ Powell","year":"2015","unstructured":"Powell RJ, Leech SC, Till S, Huber PAJ, Nasser SM, Clark AT. BSACI guideline for the management of chronic urticaria and angioedema. Clin Exp Allergy. 2015;45(3):547\u201365.","journal-title":"Clin Exp Allergy"},{"key":"13122_CR30","unstructured":"AIFA. Modifica alla Nota 66 2018;G.U. n.246 del 22.10.2018. Available from https:\/\/www.aifa.gov.it\/documents\/20142\/241076\/Modifica_alla_Nota_66-G.U._n._246_del_22.10.2018.pdf."},{"key":"13122_CR31","volume-title":"Roma: agenzia Italiana Del farmaco, 2022 [The Medicines Utilisation Monitoring Centre. National Report on Medicines use in Italy. Year 2021","author":"Agenzia Italiana del Farmaco","year":"2022","unstructured":"Agenzia Italiana del Farmaco. Osservatorio nazionale sull\u2019impiego dei medicinali. L\u2019uso dei farmaci in italia. Rapporto nazionale anno 2021. Roma: agenzia Italiana Del farmaco, 2022 [The Medicines Utilisation Monitoring Centre. National Report on Medicines use in Italy. Year 2021. Rome: Italian Medicines Agency, 2022].; 2022."}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13122-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-025-13122-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13122-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T19:23:17Z","timestamp":1757272997000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-025-13122-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13122"],"URL":"https:\/\/doi.org\/10.1186\/s12913-025-13122-9","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"9 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This was a retrospective, cohort, observational study. Fully anonymized data were extracted from the administrative databases of Italian Regional\/Local Health Authorities, owners of the data. National legislation and institutional requirements do not require for ethical approval and consent to participate for this study, according to European Regulations 2014\/536 [] and 2016\/679 [], to which the Regional\/Local Authorities owners of the data have agreed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"969"}}